Latest / Conversations with CEI
Talking to patients about Lenacapavir (Sunlenca); the new long-acting injectable medication for HIV
In this episode, Dr. Steven Fine, an infectious disease specialist affiliated with the University of
Rochester and Anthony Jordan Health Center explains the pros and cons behind the newly
approved Lenacapavir (Sunlenca) injectable for HIV.
Dr. Fine receives a lot of questions about the medication in his practice. Many patients have
heard good things about the new treatment for HIV that is given as a subcutaneous injection
once every 6 months. Dr. Fine discusses the current indication in combination with other agents
for “treatment-experienced” HIV patients and possible future uses. You’ll…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.